biotechs are usually stocks to avoid like the plague for small investors. However, I've taken a 6-month view in this one because they appear to have some runs on the board already and they don't issue BS announcements full of misleading garbage. What's most unusual is they have a very small share register, spec biotechs usually have telephone number sized registers. Let's see how it goes.
